Torrent Pharmaceuticals Q2 Results Live : Torrent Pharmaceuticals declared its Q2 results on October 25, 2024, showcasing a robust performance with a topline increase of 8.61% year-on-year and a profit rise of 17.36% compared to the same quarter last year.
However, when compared to the previous quarter, the revenue experienced a modest growth of 1.05%, while profits saw a slight decline of 0.88%. This indicates a stable performance despite the quarter-on-quarter fluctuations.
The company’s Selling, General & Administrative expenses saw a decline of 1.27% quarter-on-quarter, although they increased by 7.95% year-on-year, reflecting ongoing efforts to manage costs effectively.
Operating income was up by 4.81% compared to the previous quarter and increased significantly by 18.75% year-on-year, illustrating improved operational efficiency.
The earnings per share (EPS) for Q2 stood at ₹13.37, reflecting a year-on-year increase of 17.38%, contributing positively to shareholder value.
In terms of market performance, Torrent Pharmaceuticals has delivered a -2.22% return in the last week, but a noteworthy 23.27% return over the last six months and an impressive 44.06% year-to-date return.
The company’s current market capitalization is ₹112,407.9 Crores, with a 52-week high of ₹3,590.7 and a low of ₹1,859.55, indicating strong market positioning.
As of October 26, 2024, out of 27 analysts covering Torrent Pharmaceuticals, the consensus recommendation is to Buy, with 1 Strong Sell, 3 Sell, 6 Hold, 13 Buy, and 4 Strong Buy ratings, highlighting positive sentiment among market experts.
Torrent Pharmaceuticals Financials
| Period | Q2 | Q1 | Q-o-Q Growth | Q2 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 2889 | 2859 | +1.05% | 2660 | +8.61% |
| Selling/ General/ Admin Expenses Total | 543 | 550 | -1.27% | 503 | +7.95% |
| Depreciation/ Amortization | 198 | 197 | +0.51% | 201 | -1.49% |
| Total Operating Expense | 2148 | 2152 | -0.19% | 2036 | +5.5% |
| Operating Income | 741 | 707 | +4.81% | 624 | +18.75% |
| Net Income Before Taxes | 661 | 656 | +0.76% | 559 | +18.25% |
| Net Income | 453 | 457 | -0.88% | 386 | +17.36% |
| Diluted Normalized EPS | 13.37 | 13.51 | -1.04% | 11.39 | +17.38% |
